학술논문

How will the identification and therapeutic intervention of genetic targets in oncology evolve for future therapy?
Document Type
Article
Source
Expert Opinion on Therapeutic Targets; December 2023, Vol. 27 Issue: 12 p1189-1194, 6p
Subject
Language
ISSN
14728222; 17447631
Abstract
ABSTRACTIntroductionMapping of the human genome, together with the broad understanding of new biomolecular pathways involved in cancer development, represents a huge dividing line for advances in cancer treatment. This special article aims to express the next evolution of cancer therapy, while also considering the challenges and uncertainties facing future directions.Area coveredThe recent achievements of medical science in the oncology field concern both new diagnostic techniques, such as liquid biopsy, and therapeutic strategies with innovative anticancer drugs. Although several molecular characteristics of tumors are linked to the tissue of origin, some mutations are shared by multiple tumor histologies, thus paving the way for what is called ‘precision oncology.’ The article highlights the importance of identifying new mutations and biomolecular pathways that can be pursued with new anticancer drugs.Expert opinionOncology and medical science have made great progress in understanding new molecular targets; being able to early identify tumor markers that are not confined to a single organ through minimally invasive diagnostic techniques allows us to design new effective therapeutic strategies. Multidisciplinary teams now aim to evaluate the most appropriate and personalized diagnostic/therapeutic approach for the individual patient.